TP53 and B-cell chronic lymphocytic leukemia: The CLL International Prognostic Index (CLL-IPI) considers age, immunoglobulin heavy chain (IGHV) mutation status, TP53 mutation or deletion, staging information (Binet or Rai) [262], and serum β2-microglobulin levels.